Clinical Trial Update: Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise [Phase 3]

View source ↗

Summary

Phase 3 trial comparing efpeglenatide to placebo in adults with type 2 diabetes inadequately controlled with diet and exercise; study completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• efpeglenatide (efpeglenatide)

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2022-01-18